A new “Zero+” version of a proposed World Health Organization pandemic accord being negotiated by member states has dropped previously strong language that conditioned use of public R&D funds to private sector commitments to price transparency and tech transfer of end products, among other measuress. However, the updated draft text, obtained by Health Policy Watch, […] Continue reading ->
As a wave of cholera outbreaks spreads around the world, Gavi, the Vaccine Alliance said it expects the global shortage of oral cholera vaccines to continue until the end of 2025. Supply of oral cholera vaccines for preventative use could catch up to demand by 2026, but “urgent action is needed,” according to a vaccine […] Continue reading ->
The call and response of “Yes we can, end TB” at the Multi-Stakeholder Hearing (MSH) on tuberculosis (TB) made one thing clear — the voices of the community will be heard. With negotiations of the UN Political Declaration now underway, what does the TB community expect to see? Members of the global TB community, including […] Continue reading ->
 The HIV pandemic has affected over 2.3 million people in the World Health Organization’s (WHO) European Region, with nearly 300 new diagnoses made daily in 2021. The COVID-19 pandemic and geopolitical turbulences in the region impacted the course of the HIV pandemic and the response, displacing populations, and disrupting access to care and HIV testing. […] Continue reading ->
Regional vaccine production features in the draft pandemic accord, but there is still a long road before this becomes a reality Aspen Pharmacare invested millions of dollars in scaling up its South African production plant to make COVID-19 vaccines – yet it never sold a single vial. Meanwhile, in a “demoralising blow”, Bangladesh’s government rejected […] Continue reading ->
The World Health Organization (WHO) has ended the global health emergency for mpox, marking the end of a 10-month juggling act by the UN health agency as it scrambled to deal with concurrent global pandemics.  The announcement arrives just days after WHO declared the end of the global health emergency for COVID-19 last Friday, three […] Continue reading ->
HIV activists want the US government to appeal Tuesday’s court ruling that pharmaceutical company Gilead did not infringe on patents held by the Centers for Disease Control and Prevention (CDC) related to two anti-retroviral (ARV) drugs. The US government had claimed $1 billion in patent violations in relation to the use of Gilead’s Truvada and […] Continue reading ->
The United Nations (UN) is hosting three multi-stakeholder meetings in New York on Monday and Tuesday on tuberculosis, pandemic prevention, preparedness and response (PPPR) and universal health coverage (UHC). They are aimed at getting the views of non-state actors in preparation for UN High-Level meetings in September, starting with pandemic preparedness on 20 September, followed […] Continue reading ->
The US Food and Drug Administration (FDA) has approved the first-ever vaccine for respiratory syncytial virus (RSV). The single-shot vaccine intended for use in adults aged 60 or older represents the culmination of six decades of research to protect the world from RSV. With the green light from the FDA on Wednesday, GSK’s Arexvy vaccine […] Continue reading ->